Remember meForgot password?
    Log in with Twitter

biosimilars News

Government of British Columbia expands biosimilar medicines

The Government of British Columbia has announced a program in which patients taking originator biologic drugs will be "switched" or transitioned by their clinicians to a biosimilar biologic drug within a six-month period.

U.S. approves first biosimilar medicinal product

The U.S. Food and Drug Administration (FDA) has approved pharma company Sandoz’s drug Zarxio. This is a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

Search Digital Journal Archives

Set up a news alert for


biosimilars Image

Latest News
Top News